CollPlant Holdings Ltd. (TASE: CLPT) has raised NIS 3.7 million (about $1 million) at a price of 23% above the minimum set due to surplus demand from institutions and the public at NIS 0.37 (about 0.10 Cent) per share with an issue that was 4.5 times oversubscribed. Collplant produces human...
Read more
Blog
Gene Synthesis Provider to Debut at Biotech China
GenScript , the largest gene synthesis provider in the U.S, and a leading biology CRO in the world, has recenetly confirmed participation at 2014 Biotech China. GenScript is a leading biology CRO focusing exclusively on early drug discovery and development services. Built on an assembly-line mode, one-stop solution, continuous improvement,...
Read more
Cell Cure Gets Grant for AMD
Cell Cure Neurosciences Ltd. has been awarded a grant of NIS 6.1 million for 2014 from the Office of the Chief Scientist at Israel’s Ministry of Economy. The grant will help finance the development of OpRegen, a cell-based therapeutic product for the treatment of age-related macular degeneration. The dry form...
Read more
Hadasit Signs $4M Imaging Deal
Hadasit has signed a $4 million license and cooperation agreement with Poland’s Synektik SA (WSE: STE) to develop new imaging agents for non-invasive diagnosis of cardiovascular diseases. Synektik will finance research and pre-clinical development of the imaging agents over DIDN’T Tonic I buying cialis online reminds because 40 to t...
Read more
How Much Is Your Patent Worth
In collaboration with a senior patent licensing expert, BioIsrael is offering a new service that enables companies and individuals to establish the worth of a patent that they are holding in today’s market: The new service analyzes the following value indicators: Backward citations, forward citations, the number of claims, the...
Read more